The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...
The inquiry is looking into a politically explosive suggestion that Pfizer delayed announcing a successful vaccine against ...
Pfizer (NYSE:PFE) shares reached a session low on Wednesday after The Wall Street Journal reported that the U.S. attorney’s office in Manhattan has started an investigation into whether the New ...
Blujepa, which treats UTIs in female patients aged 12 and up with common and uncomplicated infections, will hit the market in ...
The drug is a needed new option for treating uncomplicated UTIs, a common infection that’s becoming harder to treat as rates ...
19h
Zacks Investment Research on MSNGSK Secures FDA Nod for Oral Antibiotic to Treat Urinary Tract InfectionGSK plc GSK announced that the FDA has approved its oral antibiotic gepotidacin for treating uncomplicated urinary tract ...
The U.S. Food and Drug Administration has approved Blujepa (gepotidacin) for the treatment of uncomplicated urinary tract ...
This action was surfaced by Law.com Radar, which delivers real-time alerting on new litigation across more than 2,600 state and federal courts. Click here to get started and be first to act on ...
In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...
Black and American Indian patients are less likely to have elevated cancer antigen (CA)-125 levels at ovarian cancer ...
Which company has replaced IBM as the largest employer in Research Triangle Park? And who are the top hirers in Wake, Durham, ...
Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results